QUICKSCOPE HOLDINGS LTD – Trademark Portfolio

Entity Type: 11

QUICKSCOPE HOLDINGS LTD holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 25 (Clothing) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include F.P.S., OUTBREAK, PATHOGEN, and CAFFEINE & VIOLENCE. The owner is based in ROAD TOWN TORTOLA.

INTERSHORE CHAMBERS

ROAD TOWN TORTOLA , VG

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

QUICKSCOPE HOLDINGS LTD's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (5 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does QUICKSCOPE HOLDINGS LTD have?

QUICKSCOPE HOLDINGS LTD has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 cancelled.

What trademark classes does QUICKSCOPE HOLDINGS LTD file in?

QUICKSCOPE HOLDINGS LTD files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are QUICKSCOPE HOLDINGS LTD's most well-known trademarks?

QUICKSCOPE HOLDINGS LTD's registered trademark portfolio includes well-known marks such as F.P.S., OUTBREAK, PATHOGEN, and CAFFEINE & VIOLENCE. These are among 4 currently registered trademarks in the portfolio.

What is QUICKSCOPE HOLDINGS LTD's trademark registration success rate?

QUICKSCOPE HOLDINGS LTD has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.